Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$RMED $MMMW watch. $MMMW news about great solar tracker with no toxic debt and low float should help.
Gold Bullion price skyrocketing today on numbers coming in
Both $RMED $MMMW great news and good to read.
$KRTL Medflow, an AI-powered telemedicine solution provider, combines best-in-class facial recognition biometrics with next-generation zero-trust security architecture to accurately verify patient identities. Their comprehensive suite of telemedicine tools, designed with security at the forefront, includes features like end-to-end encryption, facial recognition with ID scan, and HIPAA compliance. The platform allows healthcare providers to review and legally sign medical and legal documentation live with the patient, issue prescriptions, and capture patient vitals such as heart rate, blood pressure, breathing, and stress indicators, all using the patient's computer or mobile phone camera.
https://www.marketwatch.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-2023-05-30?mod=mw_quote_news_seemore
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$RMED Ra Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO System
https://www.accesswire.com/760298/Ra-Medicals-Electrophysiology-Division-Announces-First-Hospital-to-Complete-100-Procedures-Using-the-VIVO-System
$KRTL and $MMMW news on focus and technologies. Worth reviewing.
$KRTL In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$KRTL Daniel Ball, CEO of KRTL Biotech, is excited about this partnership. He states, "Our collaboration with Medflow is a significant step forward in our mission to enhance patient care in the alternative wellness sector. The integration of Medflow's state-of-the-art telemedicine platform will allow us to provide secure and robust health-related services remotely in the alternative wellness market."
https://www.nasdaq.com/press-release/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered
$KRTL We are interested in having a competitive edge in the marketplace, through mergers & acquisitions, collaborations, and strategic alliances with specific partners.
$PLPL and $MMMW patent and technology news. $MMMW has only an 80 million share float with less than $2 million market cap.
$KRTL ~ KRTL Partnered to Bring Comprehensive Cloud and Endpoint Security and AI Powered Telemedicine Solutions
https://finance.yahoo.com/news/krtl-partnered-bring-comprehensive-cloud-130000765.html
$PLPL A key component to the assessment was ByoPlanet's intellectual property, which the Company believes is both groundbreaking and consistently outperforms competitors.
https://www.barrons.com/articles/third-party-valuation-firm-provides-estimated-valuation-of-byoplanet-s-a-subsidiary-of-plandai-plpl-business-and-assets-a3a1dbe9?mod=md_stockoverview_news
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$EMED When it comes to electricity created in the human body, the energy source is chemical and has to do with the composition of the atoms and molecules present. All the elements we take into our bodies, such as oxygen, sodium, potassium, calcium, magnesium etc., have a specific electrical charge. How those molecules are bound together and how they react to other molecules near them is how chemicals create energy. Some of these electrical impulses found naturally in our bodies activate functions needed for healing.
$SGTM Launching into 2023 with Vision & Strategy
$PVSP Investment Bankers want PVSP to diversify from just Recreational Cannabis
"Expect a Series of Related Transactions"
PVSP 100 M shares of Common Stock with NO Debt, No Convertibles, No Special Series Stock, simple and clean share structure, every shareholder get the same type of Common Stock with one vote per share, as it should be.
If you own 1% of PVSP, you will get 1% ownership in Artizen Spin Off. Totally Fair and straight forwar
$PVSP
Artizen will only have Common Stock, NO other Series!
$PVSP Investment Bankers want PVSP to diversify from just Recreational Cannabis
"Expect a Series of Related Transactions"
$PVSP Positioning for Expansion
“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.
https://seekingalpha.com/pr/19084459-pervasip-announces-artizen-spin-off
$PVSP Key Highlights
Instead of focusing on a rollout of licensed Dabs and Vape4Less brands, the Company pursued an outright acquisition of those brands plus others, achieving more beneficial long-term value but not yet realizing respective revenue gains as indicated earlier.
Q3 shows margin improvement over Q2 as higher margin brands and products are coming online, a trend that will continue into Q4 2022.
The Company continues to pursue additional operational, financial, and legal restructuring to further clean and strengthen its balance sheet.
While expensive, the Company will continue to seek capital from available equity or debt sources.
The cannabis market on the Westcoast continues to see a dramatic post-pandemic retraction, creating a challenging environment for all producers, processors, and retailers. With an almost 18% contraction in retail revenues, massive oversupply, sustained downward price pressure and increasing costs, the industry is still months away from a recovery, although the bottom for pricing seems to have been reached.
https://www.morningstar.com/news/globe-newswire/8666987/pervasip-announces-3rd-quarter-financials
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP After initial trials (3 - 4 months), once we believe we have the right genetics for certain strains, we clone for commercial rollout (~14 days), then let those clones grow into teens (14-18 days), then flip them into our flower rooms to grow into adult females (8-9 weeks)...
$PVSP company will acquire substantially all of the assets of BCCTG LLC (“BCCTG”).
BCCTG, owner of various brands, including Emerald City Cultivation, Emerald City Cured, Dabco, Dabs4Less and Vapes4less has agreed to terms to be acquired by ZAM, combining its brands and concentrate offerings with ZAM’s Artizen brands to form a powerful portfolio of brands, covering flower, pre-roll, dabbable concentrates and vape products.
$PVSP we are Artizen cannabis and we are expanding rapidly nationwide and international markets too!
$MULN The company brings a significant pipeline of interest from large companies for commercial electric truck classes 3-6 in a wide range of markets such as last-mile delivery, refrigeration, utilities, and their upfitters. On Sept. 1, 2022, Bollinger revealed the B4, a class 4 electric commercial truck, for the first time. The B4 electric chassis cabs will be the first of the company’s commercial lineup to hit the ground in upcoming client test programs. The new Bollinger B4 incorporates years of feedback from dozens of major fleets looking to electrify their vehicles. https://www.mullenusa.com/bollinger-mullen
$GOGY Golden Grail Technology (OTCPK:GOGY) has filed to reduce its current authorized share count from 5 billion to 500 million.
$GCT $SIGA $STBX $GOVX $GOGY $LTNC $NICH $LFAP $AZFL
$IJJP eCETP client enrollment.
Certified eCETP Operators
TOTALS CATEGORY
1 Nonprofit -Perpetual License
1 Nonprofit -eCETP User
1 For-Profit -eCETP Partner
Mandatory Training Program
TOTALS CATEGORY
2 Nonprofit -eCETP Users
1 For-Profit -eCETP Partner
https://stockhouse.com/news/press-releases/2022/10/14/ijj-corporation-expansion-activities-for-board-members-as-appointed-officers-the
$PVSP Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net.
https://www.barrons.com/articles/pervasip-announces-1-6-million-in-august-revenues-and-3rd-quarter-guidance-01663075206?mod=md_stockoverview_news
$PVSP's Financial Outlook Q3 2022 through Q4 2023:
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP We also invested in a small Korea based research entity, KRTL, to establish an early foothold in the rapidly expanding world of medical fungi, with a specific focus on Psilocybin. It is an entry to a large database of related research, various research entities actively involved in related development projects and provides Pervasip with a perfect perch to look at various fungi opportunities across the globe.
$PVSP 24 Months plan detail
Rename Pervasip Corp to Artizen Corporation by year end 2022 to better reflect the new focus of the company
Change the OTC ticker symbol
Re-brand all Pervasip/Artizen assets
Continue to rationalize the business through Q1 2023 with a focus on operating margins, shedding underperforming assets, consolidating operations and focus in-house talent on higher margin operations and product lines
Acquire concentrates assets by end of 2022, launching into the highly lucrative concentrates business
Expand flower and concentrates offerings within our brands as well as adding new brands for certain product offerings and price points through Q1 2023
Complete the audit and begin the OTC QB application process during Q2 2023
Launch Artizen Wellness Q2 2023
Enter the edibles market in Q2 2023 via acquisition and partnerships
Artizen becomes an MSO with cultivation and retail assets in 1 – 2 additional states during 2nd half of 2024, beginning its state expansion in Q1 2023, initially through brand licensing opportunities and strategic partnerships, and eventually via acquisitions and mergers during Q3 and Q4 2024
Close first brand licensing agreement by end of Q4 2022
Close one brand licensing deal every quarter thereafter
Financial Outlook Q3 2022 through Q4 2023
Reach $2.0 million in monthly revenue by end of Q1 2023
Reach $2.5 million or $30 million in annualized revenue by end of Q4 2023 with 30% in adjusted EBIDTA
Reach $3.0 million or $36 million in annualized revenues by end of Q2 2024 with 35% in adjusted EBIDTA
Reach $50 million in annualized revenue with 35% in adjusted EBIDTA
$PVSP For all cannabis connoisseurs all that needs to be said about that brand is “IYKYK” (bestselling small batch top shelf brand). Several similar arrangements will be announced soon, following through on one of the other major initiatives outlined in the January 2022 Shareholder letter.
While the cannabis market on the west coast is still challenged by its post Covid dip, massive oversupply, and egregious tax and state by state rules, brands like ArtizenTM, well-oiled distribution, top notch management teams and healthy, transparent financial structures, will be the ultimate winners in this space.
$HTSC, super low float. Assets greater than market cap.
$PVSP Seattle, WA, July 21, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTCPK: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced the decision to reduce the Company’s authorized shares and provide new guidance on reverse splits.
https://seekingalpha.com/pr/18874549-pervasip-announces-2-billion-authorized-share-reduction-and-no-reverse-splits-for-5-years
$PVSP Quarter over quarter EBITDA has increased from ($649,831) to $124,221
$PVSP Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net.
https://www.benzinga.com/pressreleases/22/07/g28151445/pervasip-announces-2-billion-authorized-share-reduction-and-no-reverse-splits-for-5-years
$HTSC The Company has uploaded its June 30, 2022 consolidated financial statements to OTC Markets. Please refer to the financial statements for complete details of the Company's third quarter fiscal 2022 operating results.
https://www.marketwatch.com/press-release/here-to-serve-holding-corp-reports-nine-month-operating-income-of-1320883-with-revenues-of-1935374-2022-08-15?mod=mw_quote_news_seemore
$HTSC Here To Serve Holding Corp. is a holding company with three operating entities. Its subsidiary Fortune Nickel and Gold Inc. owns 182 mining cells in the Timmins mining camp in Ontario, Canada, which is highly prolific to nickel, gold and copper. The nickel is targeted as a battery metal for electric vehicles.
The subsidiary ICF Industries Inc. owns a diversified basket of minority positions in publicly traded equities. It receives these equity positions in exchange for marketing and financial reporting services. The market value of its investment portfolio is $1,987,700 on June 30, 2022.
ICF Industries Inc. also works with affiliate KRTL Biotech. A doctor at KRTL Biotech has MFDS approval to study psilocybin in South Korea with its team of doctors, chemists, and researchers. They believe they can work with us to give people new ways to heal.
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
https://stockhouse.com/news/press-releases/2022/08/15/here-to-serve-holding-corp-reports-nine-month-operating-income-of-1-320-883-with
$BLEG Acquisition Done
LOI - Branded Legacy, Inc. Signs LOI To Acquire First Patent
Press Release | 5/26/2022
https://tinyurl.com/2p998nn7
LOI - Branded Legacy, Inc. Signs Letter of Intent to Acquire Kamino Propagation & Research, LLC
Press Release | 04/06/2022
https://tinyurl.com/2s3km6zj
LOI -Branded Legacy, Inc. Signs Letter Of Intent To Acquire All In Extracts, LLC
Press Release | 03/17/2022
https://tinyurl.com/yc2yxn4f
$TINO We are currently negotiating some interesting prospects that we have targeted, and we have signed agreements under clauses enforcing exclusivity on important properties while working with expert advisors in the field.
https://canadatoday.news/on/tamino-is-continuing-its-transition-to-focus-on-mining-lithium-in-south-america-for-the-electric-vehicle-ev-industry-15135/
$PVSP "Hello $PVSP shareholders: We are pleased to announce we are in the final phase of closing a strategic partnership that management believes will add an enormous amount of revenue to our bottom line. We look forward to announcing the details soon. Stay tuned!"
Hello $PVSP shareholders: We are pleased to announce we are in the final phase of closing a strategic partnership that management believes will add an enormous amount of revenue to our bottom line. We look forward to announcing the details soon. Stay tuned!
— Pervasip Corp (@PervasipC) April 19, 2022
$TINO Sonora remains the undisputed champ #1 Gold Producer in Mexico #Gold #Silver #PreciousMetals
$PVSP Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net.
https://www.benzinga.com/pressreleases/22/07/g28151445/pervasip-announces-2-billion-authorized-share-reduction-and-no-reverse-splits-for-5-years
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6058
|
Created
|
07/24/12
|
Type
|
Free
|
Moderator Aufklaerung | |||
Assistants MaxPowerLove$Ihub StockMasterTalk |
Posts Today
|
0
|
Posts (Total)
|
6058
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |